The inhibition of Wnt/β-catenin signaling pathway in human colon cancer cells by sulindac

Tumori

Volumn 100, Issue 1, 2014, Pages 97-101

  Tai, Wei Ping ^a,b   Hu, Pin Jin ^b   Wu, Jing ^a   Lin, Xiang Chun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Colorectal cancer; NSAIDs; Wnt b catenin

Indexed keywords

BETA CATENIN; SULINDAC; WNT PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRAIN HT29; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; MITOSIS INHIBITION; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BETA CATENIN; BLOTTING, WESTERN; CASPASE 3; CELL PROLIFERATION; COLORECTAL NEOPLASMS; COLORIMETRY; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HT29 CELLS; HUMANS; SIGNAL TRANSDUCTION; SULINDAC; TIME FACTORS; WNT PROTEINS;

EID: 84896950015     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Corrêa Lima MP, Gomes-da-Silva MH: Colorectal cancer: lifestyle and dietary factors. Nutricion Hospitalaria, 20: 235-241, 2005.
2. Fujita S, Yamamoto S, Akasu T, Moriya Y: Prognostic factors of rectal cancer patients with lateral pelvic lymph node metastasis. Hepatogastroenterology, 59: 2494-2497, 2012.
3. Senda T, Iizuka-Kogo A, Onouchi T, Shimomura A: Adenomatous polyposis coli (APC) plays multiple roles in the intestinal and colorectal epithelia. Medical Molecular Morphology, 40: 68-81, 2007.
4. Fuchs SY, Ougolkov AV, Spiegelman VS, Minamoto T: Oncogenic beta-catenin signaling networks in colorectal cancer. Cell Cycle, 4: 1522-1539, 2005.
5. Clevers H: Wnt/β-catenin signaling in development and disease. Cell, 127: 469-480, 2006.
6. Kobayashi M, Honma T, Matsuda Y, Suzuki Y, Narisawa R, Ajioka Y, Asakura H: Nuclear translocation of beta-catenin in colorectal cancer. Br J Cancer, 82: 1689-1693, 2000.
7. Takahashi-Yanaga F, Sasaguri T: The Wnt/beta-catenin signaling pathway as a target in drug discovery. J Pharmacol Sci, 104: 293-302. 2007.
8. Shan BE, Wang MX, Li RQ: Quercetin inhibits human SW480 colon cancer growth in association with inhibition of cyclin D and survivin expression through Wnt/β-catenin signaling pathway. Cancer Invest, 27: 604-612, 2009.
9. Hixson LJ, Earnest DL, Fennerty MB, Sampliner RE: NSAID effect on sporadic colon polyps. Am J Gastroenterol, 88: 1652-1656, 1993.
10. Hixson LJ, Alberts DS, Krutzsch M, Einsphar J, Brendel K, Gross PH, Paranka NS, Baier M, Emerson S, Pamukcu R, Burt RW: Antiproliferative effect of nonsteroidal antiinflammatory drugs against human colon cancer cells. Cancer Epidemiol Biomarkers Prev, 3: 433-438, 1994.
11. Vijayakurup V, Carmela S, Carmelo D, Corrado T, Srinivas P, Gopala S: Phenethyl caffeate benzo[kl]xanthene lignan with DNA interacting properties induces DNA damage and apoptosis in colon cancer cells. Life Sci, 91: 1336-1344, 2012.
12. Vaish V, Tanwar L, Kaur J, Sanyal SN: Chemopreventive effects of non-steroidal anti-inflammatory drugs in early neoplasm of experimental colorectal cancer: an apoptosome study. J Gastrointest Cancer, 42: 195-203, 2011.
13. Dihlmann S, Siermann A, von Knebel Doeberitz M: The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling. Oncogene, 20: 645-653, 2001.
14. Holcombe RF, Marsh JL, Waterman ML, Lin F, Milovanovic T, Truong T: Expression of Wnt ligands and frizzled receptors in colonic mucosa and in colon carcinoma. Mol Pathol, 55: 220-226, 2002.